BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 9, 2014
View Archived Issues
Scientists develop paper-based, cell-free, stable, synthetic gene network arrays
Read More
Genmab confirms phase II study of daratumumab in non-Hodgkin's lymphomas
Read More
NeuroSolis presents novel M1/M4-selective agonists for Alzheimer's disease
Read More
Characterization of a potent and selective PDE10A inhibitor, RO-5461861
Read More
Idenix presents phase I/II data for MK-3682 in patients with HCV infection
Read More
Acetylon initiates phase II multiple myeloma study of ricolinostat in combination with Pomalyst
Read More
ProMetic to evaluate PBI-4050 in new indication
Read More
Phase III data presented from the MOBILITY trial evaluating sarilumab in patients with RA
Read More
NCI contracts MRIGlobal to develop HPV vaccine
Read More
EMA determines no evidence that Fluad caused deaths in Italy
Read More
CCX-168 receives European orphan designation for ANCA-associated vasculitis
Read More
Pluristem collaborates with Hadassah Medical Center on PLX-RAD
Read More
Sichuan Haisco Pharmaceutical patents novel SGLT2 inhibitors
Read More
Kalvista Pharmaceuticals reports selective plasma kallikrein inhibitors
Read More
Phase I data for the Notch signaling inhibitor BMS-906024 in patients with T-ALL and T-LL
Read More
Alnylam files application to conduct U.K. trial of ALN-CC5 in PNH
Read More
Basilea re-introduces antibiotic ceftobiprole medocaril
Read More
BTG to acquire PneumRx
Read More
Takeda launches global oncology business unit Takeda Oncology
Read More
Sunovion files sNDA for Aptiom as monotherapy for partial-onset seizures
Read More
FDA committee votes on Actavis' NDA for ceftazidime/avibactam
Read More
Lutinus for luteal supplementation launched in Japan
Read More
Daiichi Sankyo launches Lixiana in Japan for new indications
Read More
FDA approves Xgeva for hypercalcemia of malignancy
Read More
European approval for Moventig for opioid-induced constipation
Read More